METHODOLOGY OF THE DRUGS MARKET VOLUME MODELING ON THE EXAMPLE OF HEMOPHILIA A
Hemophilia A is a serious genetic disease, which may lead to disability of a patient even in early ages without a required therapy. The only one therapeutic approach is a replacement therapy with drugs of bloodcoagulation factor VIII (FVIII). The modeling of coagulation drugs market volume will allo...
Saved in:
| Main Author: | N. B. Molchanova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute
2015-12-01
|
| Series: | Фармация и фармакология (Пятигорск) |
| Subjects: | |
| Online Access: | https://www.pharmpharm.ru/jour/article/view/174 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MYOCARDIAL INFARCTION AND HEMOPHILIA
by: A. S. Galyavich, et al.
Published: (2016-03-01) -
Determining the Prognostic Value of Coagulation Parameters and D-dimer Plasma Level in Admitted COVID-19 Patients
by: Maryam Ghasemi, et al.
Published: (2022-08-01) -
Gene-based therapies for hemophilia
by: Melissa F. Glasner, et al.
Published: (2025-05-01) -
Assessing stigma in a predominantly male hemophilia population: a Chinese cross-sectional study
by: Lijuan Ye, et al.
Published: (2025-06-01) -
Marstacimab for the Treatment of Hemophilia A or B
by: Mahlangu J
Published: (2025-06-01)